Tag: Prescription Drugs
Anti-VEGF Therapy May Aid Visual Acuity in Some nAMD Patients
Useful visual acuity preserved for about 20 percent of patients over their average remaining lifetime
Upadacitinib Tops Abatacept for RA Refractory to DMARDs
Superior for mean change in composite DAS28-CRP values and remission, but more adverse events seen
FDA Requiring Labeling Changes to NSAIDs Warning of Risks in Pregnancy
Labeling must indicate risks to unborn baby with NSAID use at 20 weeks of pregnancy or later
Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events
Polypharmacy Common in Seniors With Heart Failure
With increasing number of medications, more rapid increase seen in number of noncardiovascular meds
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
COVID-19 Antibody Treatment Study Paused
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused 'out of an abundance of caution'
One Size May Not Fit All for Postoperative Opioid Prescribing
Guidelines reduce postoperative opioid prescribing but may result in inadequate pain control for some
Remdesivir Cuts Time to COVID-19 Recovery
However, no significant difference in mortality found between remdesivir and placebo groups
Poll: Medication Management Lacking in Older Adults
Most older adults taking multiple medications have never had a comprehensive medication review
